RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. More
Articles
TNYA Stock Earnings: Tenaya Therapeutics Beats EPS for Q2 2024
TNYA stock results show that Tenaya Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
SANA Stock Earnings: Sana Biotechnology Misses EPS for Q2 2024
SANA stock results show that Sana Biotechnology missed analyst estimates for earnings per share the second quarter of 2024. More
SNOA Stock Earnings: Sonoma Pharmaceuticals Misses EPS, Misses Revenue for Q1 2025
SNOA stock results show that Sonoma Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2025. More
SENEA Stock Earnings: Seneca Foods Reported Results for Q1 2025
Seneca Foods just reported results for the first quarter of 2025. More
SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024
SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
SABS Stock Earnings: SAB Biotherapeutics Beats EPS for Q2 2024
SABS stock results show that SAB Biotherapeutics beat analyst estimates for earnings per share the second quarter of 2024. More
